
Home Chapter Home Jobs Conferences Fellowships Books
Advertisement
Breast-malignant, males, children
Lipid rich carcinoma
Author: Nat Pernick, M.D, PathologyOutlines.com, Inc.
Reviewer: Daniel Visscher, M.D., University of Michigan Hospitals, February 2009 (see Reviewers page)
Revised: 13 April 2010
Last major update: September 2009
Copyright: (c) 2002-2010, PathologyOutlines.com, Inc.
Definition
=========================================================================
● 90%+ cells have prominent intracytoplasmic neutral lipid
Clinical
=========================================================================
● Rare; 1-2% of breast carcinomas
● Axillary metastases may resemble histiocytes
Treatment and prognosis
=========================================================================
● Poor prognosis due to frequent (70%) nodal metastases at presentation
Case reports
=========================================================================
● 53 year old woman (Acta Chir Belg 2008;108:115
● 55 year old man (Pathology 1995;27:280)
● 56 year old woman with focal chondroid metaplasia in tumor (Pathol Int 1998;48:912)
● 62 year old woman (Archives 2003;127:e396)
● 78 year old woman with solid alveolar pattern in tumor (Breast Cancer 1998;5:171)
Gross description
=========================================================================
● Lobulated, variable circumscription, firm
● 1 to 15 cm
Microscopic description / grading
=========================================================================
● Nests, cords and sheets of large polygonal cells with foamy or vacuolated cytoplasm containing lipid
● May resemble clear cells or lipoblasts
● Irregular nuclei with coarse chromatin, moderate atypia, prominent nucleoli
● Other patterns are large pleomorphic cells in alveolar pattern with hobnail appearance, oncocytic or apocrine-type change
Micro images
=========================================================================
Low power High power
Fig 1: tumor with pushing borders and lymphoplasmacytic and eosinophilic infiltrate (arrow: high grade comedo DCIS)
Fig 2: tumor composed of sheets and cords of large polyhedral cells with ill-defined borders, fine granular, eosinophilic cytoplasm and large nuclei with prominent nucleoli and coarse chromatin
Fig 3: also large clear cells with foamy or vacuolated cytoplasm; Fig 4: axillary nodal metastasis
Polygonal tumor cells with distinct cell borders
and variable cytoplasmic clearing (AFIP)
Positive stains
=========================================================================
● Lipid stains (Sudan black, Oil red O on fresh tissue)
● HER2 (71%, Tumori 2008;94:342)
Negative stains
=========================================================================
● Glycogen (PAS)
● Mucin
● Usually ER, PR
Electron microscopy
=========================================================================
● Numerous intracytoplasmic non-membrane bound lipid droplets, often within autophagocytic vacuoles
● No evidence of lipid synthesis by rough ER or Golgi complexes (Virchows Arch A Pathol Anat Histopathol 1988;413:381)
Electron microscopy images
=========================================================================
Luminal microvilli, lipid droplets and mitochondria
Differential diagnosis
=========================================================================
● Apocrine carcinoma - uniformly granular and eosinophilic cytoplasm, GCDFP-15+, no lipid
● Glycogen-rich carcinoma - clear cytoplasm, secretions are glycogen (PAS+), not lipid
● Oncocytic carcinoma - granular and markedly eosinophilic cytoplasm, no lipid
● Secretory carcinoma - low grade, PASd+ secretions, no lipid
● Xanthogranulomatous mastitis (on core biopsy) - not invasive, cells are CD68+, alpha-1-antitrypsin+ histiocytes (Pathol Int 2009;59:234)
Additional references
=========================================================================
End of Breast – Malignant, Males, Children > Lipid rich carcinoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by Copyright, (c) 2001-2009, PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions.